top of page

World Rare Disease Day 29th Feb

  • Mar 1, 2024
  • 1 min read


On February 29th, World Rare Diseases Day, as Pro Pharmaceuticals Group, we recognise the universal challenges faced by individuals living with rare diseases. Our focus on providing unlicensed medicines underscores the critical need for enhanced scientific knowledge and access to quality information for timely diagnosis. Moreover, our commitment to delivering appropriate, high-quality healthcare solutions aims to address inequalities in treatment access, alleviating the social and financial burdens often endured by patients. Additionally, we acknowledge the complexity of rare diseases, which underscores the importance of our efforts in advancing research and providing tailored pharmaceutical interventions.


 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page